ClinicaliQ Trial Snapshot
- Hypertension Management in Young Adults Personalised by Echocardiography and Clinical Outcome. — Recruiting • Non-phase study • Cardiology / Cardiovascular • NCT03762499.
- What is being tested: Baseline transthoracic echocardiography combined with routine hypertension clinic data to guide personalised management and improve cardiovascular risk stratification in young hypertensive adults.
- Patient eligibility overview: Young adults with hypertension enrolled across multiple UK centres in this longitudinal observational study, assessed through standard hypertension clinic protocols and echocardiographic screening.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
HyperEcho is a multi-centre longitudinal observational study, to investigate whether baseline transthoracic echocardiography along with routine data collected in the hypertension clinic can guide clinicians to better manage, and improve risk stratification for cardiovascular disease in young adults with hypertension. Participants are characterised as young adult patients aged between 18 to 40 years old and referred to the hypertension clinic to manage their blood pressure. The study visit will be carried out during the planned routine visit of the participants to the hypertension clinics of NHS trusts within England. Routine…
Eligibility Snapshot
- : * Participant is willing and able to give informed consent for participation in the study. * Male or Female, aged 18 - 40 years (at the time of their appointment at the hypertension clinic). * Referred for a Hypertension Clinic in England.
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.